Using Rapid Antigen Tests To Fight SARS-CoV-2

In a recent interview, with Anna-Marie MacDonald of Technology Networks, BioDot CEO and President Tony Lemmo discusses how rapid antigen tests work, how they compare to PCR tests and how the industry’s capacity for testing can be used to help slow the spread of SARS-CoV-2.

View Article